Author: Wang Peng in October this year, Hengrui announced to give up general generic projects and focus on innovative drugs and high-end generic drugs in the future
The world's first soluble insulin in China
Time of Update: 2019-12-07
The launch of novojia ® in China has brought a new individualized solution for Chinese diabetes patients to achieve comprehensive blood glucose control.
Shanghai's latest issue affects all medical people
Time of Update: 2019-11-17
We will continue to conduct full coverage supervision and inspection of high-risk products such as vaccines, blood products, special drugs, injections and implantable medical devices, and urge enterprises to produce and operate legally and in compliance with regulations.
A large number of the most professional inspectors are coming
Time of Update: 2019-11-15
▍ finishing: Chocolate On November 13, the State Food and Drug Administration issued two successive flight inspection notices, and two machinery enterprises in Shanghai and Taizhou, Zhejiang, stopped production for rectification.
Deep water area of medical AI: some big problems still need to be solved
Time of Update: 2019-11-05
What is the prediction accuracy of your product in clinical use? You just said how much accuracy has been achieved and how to ensure the safety? What is the current generation
Three pharmaceutical enterprises withdraw from the market, and the life of Chinese herbal medicine enterprises becomes more and more difficult
Time of Update: 2019-09-05
In recent years, the drug regulatory authorities have continued to increase the supervision, inspection and sampling of Chinese herbal pieces, investigate and expose illegal enterprises and unqualified products in accordance with the law.
Chinese medicine enterprises should not forget to improve product quality after they have their own "home
Time of Update: 2019-08-15
[policies and regulations of pharmaceutical network] recently, the National Health Commission and the State Administration of traditional Chinese medicine jointly issued the notice on strengthening the work of traditional Chinese medicine in the construction of medical consortia.
Issued by the State Council: establish a team of professional drug inspectors, which will be basically completed by the end of 2020
Time of Update: 2019-07-19
On July 18, the general office of the State Council issued the opinions on the establishment of a professional team of drug inspectors (hereinafter referred to as the "opinions
After the tax investigation, what are the new actions of relevant pharmaceutical enterprises
Time of Update: 2019-07-09
In addition to the actions and influences of canceling subsidiaries and falling stock prices, some pharmaceutical enterprises have also changed their positions.
How to transform private hospitals under the reform of medical insurance payment
Time of Update: 2019-06-10
However, drug price, DRG and medical insurance payer compliance are the main tools to directly curb the original development mode of private hospitals.
The fire of medical reform finally burns consumables
Time of Update: 2019-05-07
Recently, the second people's Hospital of Yibin issued the notice of the Party committee of the second people's Hospital of Yibin on the progress of inspection and rectification
Many problems behind the huge space of traditional Chinese medicine market restrict the development of industry
Time of Update: 2019-05-06
[market analysis of pharmaceutical Station] Traditional Chinese medicine is the precious wealth of the Chinese nation
In recent years, with the strong support
Be careful! Some contents of the outline of the qualification examination for licensed pharmacists have been adjusted
Time of Update: 2019-04-10
In order to do a good job in the national licensed pharmacist qualification examination in 2019, entrusted by the State Drug Administration, the National Drug Administration
Health care disorder under the banner of traditional Chinese medicine will be rectified
Time of Update: 2018-12-29
[China Pharmaceutical network industry trends] on December 27, 2018, the State Administration of traditional Chinese medicine held a special meeting to rectify the disorder of health care services under the banner of traditional Chinese medicine.
In the first three quarters of Hebei Province, the growth rate of medicine exceeded 19%, and the quality improved simultaneously
Time of Update: 2018-12-13
[China Pharmaceutical network industry trends] in recent years, Hebei pharmaceutical enterprises have focused on market demand, vigorously researched and developed new products
[latest] after zero customs clearance of anticancer drugs, imported chemical APIs and preparations will not be subject to batch by batch compulsory inspection
Time of Update: 2018-04-27
On April 26, the State Food and Drug Administration issued the announcement on matters related to customs clearance and inspection of imported chemicals (No
12 document
